Treatment of refractory hand eczema by dupilumab: A case report.

This article discusses the use of dupilumab, a medication used to treat atopic dermatitis (AD), in the treatment of refractory hand eczema (HE). The case report focuses on a 55-year-old woman with severe AD and HE who experienced excellent clinical results after receiving dupilumab therapy. The article also mentions previous studies that have shown the efficacy of dupilumab in treating different subtypes of HE. The authors conclude that dupilumab may be a viable treatment option for patients with therapy-resistant chronic hand eczema. [Extracted from the article]